Is it Finally the Right Time to Buy This Stock?

Despite the recent rally across the board, WELL Health Technologies stock remains cheap. Is it a good buy? Let’s find out!

| More on:
clock time

Image source: Getty Images

The harsh economic climate over the last few years has not been kind to several top stocks that boomed amid the pandemic. Growing inflation and higher interest rates combined to increase living costs for consumers. Publicly traded companies that rely a lot on debt to fund capital programs also suffered under the weight of financial pressure of higher borrowing costs due to higher interest rates.

The recent key interest rate cuts provided some much-needed relief to consumers and the stock market, with several high-quality Canadian stocks posting a rapid recovery. Rate cuts act like a shot of adrenaline for the stock market, as evidenced by the recent uptick in the S&P/TSX Composite Index. As of this writing, the Canadian benchmark index is up by 13.44% year to date, hovering around new all-time highs.

However, not all TSX stocks have posted a solid recovery, and there is one that might be too attractively priced right now to pass up. WELL Health Technologies (TSX:WELL) remains considerably cheap. Today, we’ll discuss whether it might be the right time to buy its shares.

WELL Health Technologies

WELL Health Technologies is a tech stock that stands out from the rest of the sector due to its involvement in the healthcare industry. The $1.09 billion market capitalization company headquartered in Vancouver is the biggest telehealth operator in the country.

It owns and operates a portfolio of outpatient health clinics. It also has several primary healthcare facilities in Canada and the U.S., providing electronic medical record services to doctors and clinics throughout Canada.

The stock came into the limelight during the pandemic, when social-distancing measures forced many to people to resort to telemedicine. It became one of the few businesses that thrived during the pandemic and saw significant growth in operations. While telehealth was already a growing industry, the pandemic put wind in its sails.

Despite consistently growing its revenue and profitability over the last few years, the end of the pandemic has seen it fall out of favour among investors. Granted, telehealth might not be as in-demand as it was during the pandemic.

Still, the company has diversified its business, allowing it to post impressive revenue growth and profitability. For any sound and seasoned investor, the fact that it trades so cheaply is surprising.

As of this writing, WELL Health stock trades for $4.38 per share. Down by over 50% from its 2021 all-time highs, it might be an excellent bet to capitalize on when investor sentiment finally reflects the intrinsic value of the underlying company.

Foolish takeaway

The shifts in the economic environment, especially over the last two years, have created several opportunities for value-seeking investors. As inflation cools off, the market volatility is making way for a rally for the broader market to reach newer heights.

Rate cuts have historically signalled improved stock market performance across the board. The current uptick in the benchmark index reflects the trend. While many stocks have already recovered to better valuations, a few lag behind the broader market.

As WELL Health stock continues growing its sales and profitability, it might be an excellent time to invest in its shares before its value soars to a fair value and beyond.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Investing

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Investing

Is Canadian National Railway Worth Buying for its 2.2% Dividend Yield?

Let's dive into whether Canadian National Railway (TSX:CNR) is a top buy for long-term investors at this point in the…

Read more »

nuclear power plant
Energy Stocks

Is Cameco Stock Still a Buy?

Cameco stock recently reported earnings that showed the Westinghouse investment is creating some major costs. But that could change.

Read more »

cloud computing
Dividend Stocks

Insurance Showdown: Better Buy, Great-West Life or Manulife Stock?

GWO stock and MFC stock are two of the top names in insurance, but which holds the better outlook?

Read more »

analyze data
Dividend Stocks

Here’s Why the Average TFSA for Canadians Aged 41 Isn’t Enough

The average TFSA simply isn't enough for most Canadians in their early 40s. Here's how to catch up.

Read more »

A plant grows from coins.
Dividend Stocks

The Smartest Dividend-Growth Stocks to Buy With $1,000 Right Now

New dividend-growth investors should consider CN Rail (TSX:CNR) stock and another top play if they're looking to build wealth over…

Read more »

concept of real estate evaluation
Dividend Stocks

How to Earn a TFSA Paycheque Every Month and Pay No Taxes on It

Canadian REITs can turn your TFSA into a monthly paycheque machine for life. Here's how Morguard North American Residential REIT…

Read more »

Start line on the highway
Investing

2 No-Brainer Growth Stocks to Buy Now With $5,000 and Hold Long Term

Market conditions today are ideal for growth investing, and two rising stocks are no-brainer buys in November.

Read more »